BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30

• Business

  Symmetry Medical Inc. Reports Third Quarter 2010 Financial Results

  November 4, 2010

   · 

  7 min read
• Pharm Country

  BioSpecifics Technologies Corporation Awarded Two Qualifying Therapeutic Discovery Project Grants

  November 4, 2010

   · 

  3 min read
• Business

  DURECT Corporation Announces Third Quarter 2010 Financial Results

  November 4, 2010

   · 

  9 min read
• Business

  Symmetry Medical Inc. Closes $200 Million Credit Facility

  November 4, 2010

   · 

  3 min read
• Biotech Bay

  Poniard Pharmaceuticals, Inc. Awarded $244,479 Grant Under Qualifying Therapeutic Discovery Project Program

  November 4, 2010

   · 

  3 min read
• Drug Development

  Study in The New England Journal of Medicine Shows Novartis Corporation Drug Afinitor(R) Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis

  November 4, 2010

   · 

  11 min read
• Deals

  Gedeon Richter Ltd. Buys Grunenthal GmbH Contraceptive Business for EUR 236.5 Million ($329.8 Million) Cash

  November 4, 2010

   · 

  3 min read
• EDP Biotech Corporation Awarded Federal QTDP Grant

  November 4, 2010

   · 

  1 min read
• Business

  Angeion Corporation Announces New Board Member

  November 4, 2010

   · 

  1 min read
• Drug Development

  4SC AG’s Vidofludimus Meets Primary Endpoint with Excellent Response Rate in Inflammatory Bowel Disease Phase II Trial

  November 4, 2010

   · 

  8 min read